Skip to main content
Back
Watch Compare

Syra Health Corp

Data quality: 100%
SYRA
OTC Services Business Services
$0.31
▲ $0.04 (16.04%)
Mkt Cap: 3.71 M
Price
$0.31
Mkt Cap
3.71 M
Day Range
$0.28 — $0.32
52-Week Range
$0.03 — $0.32
Volume
74,340
Open $0.29
50D / 200D Avg
$0.12
159.17% above
50D / 200D Avg
$0.09
236.58% above

Quick Summary

Key Takeaways

Negative free cash flow of -447,853.0
Capital efficient — spends only 0.00% of revenue on capex

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)-9.47%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-38.77%
Below sector avg (-15.95%)
ROIC-30.90%
Net Margin-12.40%
Op. Margin-12.51%

Safety

Debt / Equity
N/A
Current Ratio3.05
Interest Coverage-68.15

Valuation

PE (TTM)
-4.14
Below sector avg (-1.17)
P/B Ratio1.68
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Services sector median (502 peers)
Metric Stock Sector Median
P/E -4.1 -1.2
P/B 1.7 1.4
ROE % -38.8 -16.0
Net Margin % -12.4 -19.4
Rev Growth 5Y % — 4.0
D/E — 0.4

All Fundamental Metrics
Growth
Revenue Growth (1Y) -9.47% Revenue Growth (3Y) 14.46%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 7.23 M Net Income (TTM) -896,333.0
ROE -38.77% ROA -26.62%
Gross Margin 34.43% Operating Margin -12.51%
Net Margin -12.40% Free Cash Flow (TTM) -447,853.0
ROIC -30.90% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3.05
Interest Coverage -68.15 Asset Turnover 2.15
Working Capital 2.16 M Tangible Book Value 2.21 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4.14 Forward P/E N/A
P/B Ratio 1.68 P/S Ratio 0.51
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -12.08%
Market Cap 3.71 M Enterprise Value 1.73 M
Per Share
EPS (Diluted TTM) -0.08 Revenue / Share 0.61
FCF / Share -0.04 OCF / Share -0.04
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.00% FCF Conversion 49.97%
SBC-Adj. FCF -523,047 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023
Revenue 7.23 M 7.98 M 5.52 M
Net Income -896,333.0 -3.76 M -2.94 M
EPS (Diluted) -0.08 -0.50 -0.60
Gross Profit 2.49 M 1.65 M 1.41 M
Operating Income -904,324.0 -3.76 M -2.89 M
EBITDA — — —
R&D Expenses 67,840.0 585,146.0 240,048.0
SG&A Expenses 1.07 M 1.45 M 1.13 M
D&A — — —
Interest Expense 13,270.0 15,600.0 53,686.0
Income Tax 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023
Total Assets 2.77 M 3.68 M 4.92 M
Total Liabilities 674,739.0 800,761.0 910,072.0
Shareholders' Equity 2.10 M 2.88 M 4.01 M
Total Debt — — —
Cash & Equivalents 1.61 M 2.40 M 3.28 M
Current Assets 2.74 M 3.35 M 4.78 M
Current Liabilities 674,739.0 613,549.0 910,072.0